Thromboprophylaxis in medical–surgical critically ill patients
Authors:
- Mark A CrowtherMCMark A Crowther
- Deborah J CookDCDeborah J Cook
- 1 October 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 14 (5) , 520-523
Abstract
Although critically ill patients are at high risk of venous thromboembolism and bleeding, and thromboprophlyaxis is of proven effectivity in other settings, there remain relatively few data to assist clinicians in providing evidence-based care for medical-surgical patients in the intensive care unit. Deep vein thrombosis occurs in 5-10% of critically ill patients even if they receive unfractionated heparin for prophylaxis. Both heparin and low molecular weight heparin can be safely administered to the majority of critically ill patients and the low molecular weight heparin dalteparin does not appear to bioaccumulate even when administered to patients with severe renal dysfunction. Further research is currently underway to better define how these conditions can be optimally treated. Despite the high morbidity and mortality because of critical illness, the risk of venous thromboembolism in these patients, and adverse outcomes due to venous thromboembolism, much more methodologically rigorous data are required in the form of large, well designed randomized trials before firm recommendations about prophylaxis can be provided to this highly vulnerable population.Keywords
This publication has 28 references indexed in Scilit:
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factorsCritical Care, 2008
- Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot studyJournal of Critical Care, 2005
- Deep Vein Thrombosis and Its Prevention in Critically Ill AdultsArchives of internal medicine (1960), 2001
- Prevention of Venous ThromboembolismChest, 2001
- The Incidence of Deep Venous Thrombosis in ICU PatientsChest, 1997
- A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major TraumaNew England Journal of Medicine, 1996
- Prevention of Venous Thromboembolism in General Surgical PatientsAnnals of Surgery, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- NATURAL HISTORY OF POSTOPERATIVE DEEP-VEIN THROMBOSISThe Lancet, 1969
- ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISMThe Lancet, 1960